Skip to main content

Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients

Publication ,  Journal Article
Li, B; Ren, G; Guo, W; Zhang, J; Lam, SK; Zheng, X; Teng, X; Wang, Y; Yang, Y; Dan, Q; Meng, L; Ma, Z; Cheng, C; Tao, H; Lei, H; Cai, J; Ge, H
Published in: Frontiers in Pharmacology
September 19, 2022

Purpose: This study investigates the impact of lung function on radiation pneumonitis prediction using a dual-omics analysis method. Methods: We retrospectively collected data of 126 stage III lung cancer patients treated with chemo-radiotherapy using intensity-modulated radiotherapy, including pre-treatment planning CT images, radiotherapy dose distribution, and contours of organs and structures. Lung perfusion functional images were generated using a previously developed deep learning method. The whole lung (WL) volume was divided into function-wise lung (FWL) regions based on the lung perfusion functional images. A total of 5,474 radiomics features and 213 dose features (including dosiomics features and dose-volume histogram factors) were extracted from the FWL and WL regions, respectively. The radiomics features (R), dose features (D), and combined dual-omics features (RD) were used for the analysis in each lung region of WL and FWL, labeled as WL-R, WL-D, WL-RD, FWL-R, FWL-D, and FWL-RD. The feature selection was carried out using ANOVA, followed by a statistical F-test and Pearson correlation test. Thirty times train-test splits were used to evaluate the predictability of each group. The overall average area under the receiver operating characteristic curve (AUC), accuracy, precision, recall, and f1-score were calculated to assess the performance of each group. Results: The FWL-RD achieved a significantly higher average AUC than the WL-RD group in the training (FWL-RD: 0.927 ± 0.031, WL-RD: 0.849 ± 0.064) and testing cohorts (FWL-RD: 0.885 ± 0.028, WL-RD: 0.762 ± 0.053, p < 0.001). When using radiomics features only, the FWL-R group yielded a better classification result than the model trained with WL-R features in the training (FWL-R: 0.919 ± 0.036, WL-R: 0.820 ± 0.052) and testing cohorts (FWL-R: 0.862 ± 0.028, WL-R: 0.750 ± 0.057, p < 0.001). The FWL-D group obtained an average AUC of 0.782 ± 0.032, obtaining a better classification performance than the WL-D feature-based model of 0.740 ± 0.028 in the training cohort, while no significant difference was observed in the testing cohort (FWL-D: 0.725 ± 0.064, WL-D: 0.710 ± 0.068, p = 0.54). Conclusion: The dual-omics features from different lung functional regions can improve the prediction of radiation pneumonitis for lung cancer patients under IMRT treatment. This function-wise dual-omics analysis method holds great promise to improve the prediction of radiation pneumonitis for lung cancer patients.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Frontiers in Pharmacology

DOI

EISSN

1663-9812

Publication Date

September 19, 2022

Volume

13

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, B., Ren, G., Guo, W., Zhang, J., Lam, S. K., Zheng, X., … Ge, H. (2022). Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.971849
Li, B., G. Ren, W. Guo, J. Zhang, S. K. Lam, X. Zheng, X. Teng, et al. “Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients.” Frontiers in Pharmacology 13 (September 19, 2022). https://doi.org/10.3389/fphar.2022.971849.
Li B, Ren G, Guo W, Zhang J, Lam SK, Zheng X, et al. Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients. Frontiers in Pharmacology. 2022 Sep 19;13.
Li, B., et al. “Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients.” Frontiers in Pharmacology, vol. 13, Sept. 2022. Scopus, doi:10.3389/fphar.2022.971849.
Li B, Ren G, Guo W, Zhang J, Lam SK, Zheng X, Teng X, Wang Y, Yang Y, Dan Q, Meng L, Ma Z, Cheng C, Tao H, Lei H, Cai J, Ge H. Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients. Frontiers in Pharmacology. 2022 Sep 19;13.

Published In

Frontiers in Pharmacology

DOI

EISSN

1663-9812

Publication Date

September 19, 2022

Volume

13

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences